Clinical Trial Update: Anti IL-18 (GSK1070806) in Behcet's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of an anti-IL-18 antibody (GSK1070806) for Behcet's Disease. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behcet Disease

Drugs mentioned

• GSK1070806

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Behcet's Disease | Phase 2 | Status: UNKNOWN